Status:
COMPLETED
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Arrhythmia
Atrial Fibrillation
Eligibility:
All Genders
65-100 years
Phase:
PHASE3
Brief Summary
To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.
Detailed Description
BACKGROUND: Atrial fibrillation is an extremely common and increasingly prevalent cardiac arrhythmia, particularly in the elderly, and is an important risk factor for stroke. Management of atrial fib...
Eligibility Criteria
Elderly men and women with atrial fibrillation and other risk factors for stroke.
Key Trial Info
Start Date :
March 1 1995
Trial Type :
INTERVENTIONAL
End Date :
September 1 2002
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000556
Start Date
March 1 1995
End Date
September 1 2002
Last Update
March 25 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.